prof. Pieter Van Vlierberghe receives prestigious 'Swiss Bridge Award'

CRIG group leader Pieter Van Vlierberghe is one the four nominees that were selected out of 200 candidates by the scientific jury of the 'Swiss Bridge Award'. In his research, prof. Van Vlierberghe searches for novel drugs that could replace the current toxic chemotherapy that is used to treat children with leukemia.

Read more (in Dutch) about this award in the press release by Ghent University and in the media 'De Morgen'